次世代シーケンスサービス市場：タイプ別（ターゲット、RNA、De Novo、WES、WGS）、技術別（合成によるシーケンス、イオン半導体、SMRT、ナノポア）、用途別（研究、臨床［腫瘍、生殖］）、エンドユーザー別-2030年までの世界予測

次世代シーケンス（NGS）サービス市場タイプ別（ターゲット、RNA、デノボ、WES、WGS）技術別（合成によるシーケンス、イオン半導体、SMRT、ナノポア）アプリケーション別（調査、臨床［腫瘍学、生殖学］）エンドユーザー別-2030年までの世界予測

次世代シーケンサーサービス市場は、2023年から2030年にかけてCAGR 19.9%で成長し、2030年には203億9,000万米ドルに達すると予測されます。徹底的な2次調査と1次調査、および市場シナリオの詳細な分析に基づき、当レポートでは主要な市場促進要因、抑制要因、課題、機会について論じています。

この市場の成長は主に、NGS手順のコスト削減、新たな標的療法の開拓と承認、がんの有病率の上昇、NGSサービスプロバイダーと製薬企業間の提携、シーケンスインフラの高コスト、NGSの技術進歩に起因しています。また、シーケンスデータ解析の進歩や、がんやアグリゲノム研究におけるNGSの応用の増加は、NGSサービスプロバイダーに大きな成長機会を提供すると予想されます。

しかし、代替技術の利用可能性、サンプル調製と分析に熟練した専門家の不足、精密医療のための実用的な変異がNGSサービス市場の成長を抑制する可能性があります。さらに、診断検査における規制と標準化の懸念、非侵襲的出生前遺伝学的検査に関連する倫理的問題とコストが、この市場の成長に対する大きな課題です。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場洞察

市場
• 概要
• 市場成長に影響を与える要因
  • 影響分析
  • 要因分析
• ポーターのファイブフォース分析
• 価格分析
• 規制分析
  • 概要
  • 北米
    • 米国
    • カナダ
  • 欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
  • ラテンアメリカ
  • 中東
• 産業・技術動向
  • 社内NGSシステムの導入が市場成長の妨げに
  • 疾患診断と精密医療におけるNGSサービスの利用拡大

第5章 NGSサービス市場、タイプ別評価

• 概要
• ターゲットシーケンスサービス
• RNAシーケンスサービス
• 全ゲノムシーケンスサービス
• デノボシーケンスサービス
• エクソームシーケンスサービス
• ChIPシーケンスサービス
• メチルシーケンスサービス
• その他のNGSサービス

第6章 NGSサービス市場評価、技術別

• 概要
• 合成によるシーケンス
• イオン半導体シーケンス
• 単一分子リアルタイムシーケンス（SMRT）
• ナノポアシーケンス
• DNAナノボールシーケンス

第7章 NGSサービス市場評価、アプリケーション別

• 概要
• 調査アプリケーション
  • 創薬
  • 農業・動物研究
  • その他の調査アプリケーション
• 臨床応用
  • 腫瘍学
  • 生殖医療
  • 感染症
  • その他の臨床応用

第8章 NGSサービス市場評価、エンドユーザー別

• 概要
• 病院および診断研究所
• 製薬・バイオテクノロジー企業
• 学術機関・研究センター
• その他のエンドユーザー

第9章 NGSサービス市場評価、地域別

• 概要
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • その他欧州（RoE）
• アジア太平洋
  • 中国
  • 日本
  • インド
  • その他アジア太平洋地域（RoAPAC）
• ラテンアメリカ
• 中東・アフリカ

第10章 競合分析

• 概要
• 主要成長戦略
• 競合ベンチマーキング
• 市場シェア分析（2022年）
  • Eurofins Scientific S.E.
  • Illumina, Inc.
  • Foundation Medicine, Inc.（Subsidiary of F. Hoffmann-La Roche AG）（U.S.）
  • Invitae Corporation（U.S.）
  • Beijing Genomics Institute（BGI）（China）
  • Novogene Co., Ltd.（China）
  • Perkinelmer, Inc.（U.S.）
• 競合ダッシュボード
  • 業界リーダー
  • 市場の差別化要因
  • 先行企業
  • 新興企業

第11章 企業プロファイル

• Illumina, Inc.
• Eurofins Scientific S.E.
• Invitae Corporation
• Foundation Medicine, Inc.（Subsidiary of F. Hoffmann-La Roche AG）
• Beijing Genomics Institute（BGI）
• Novogene Co., Ltd.
• Perkinelmer, Inc.
• Macrogen, Inc.
• QIAGEN N.V.
• LGC Limited
• GENEWIZ, Inc.（Subsidiary of Azenta, Inc.）
• MedGenome, Inc.
• DNA Link, Inc.
• CD Genomics
• Otogenetics Corporation
• Quest Diagnostics Incorporated

第12章 付録

• Table 1 Incidence of Common Genetic Disorders
• Table 2 Number of New Cancer Cases, by Type, 2020 Vs. 2030
• Table 3 Biomarkers and Corresponding Targeted Therapies Currently Available
• Table 4 Pricing of Key NGS Service Providers
• Table 5 Regulatory Authorities Governing In vitro Diagnostics & NGS Products, by Country/Region
• Table 6 NGS Services: Standards and Compliance Guidelines for Laboratories
• Table 7 Biomarkers and Corresponding Targeted Therapies Currently Available
• Table 8 Global NGS Services Market, by Type, 2021-2030 (USD Million)
• Table 9 Global Targeted Sequencing Services Market, by Country/Region, 2021-2030 (USD Million)
• Table 10 Global RNA Sequencing Services, by Country/Region, 2021-2030 (USD Million)
• Table 11 Global Whole Genome Sequencing Services Market, by Country/Region, 2021-2030 (USD Million)
• Table 12 Global De Novo Sequencing Services Market, by Country/Region, 2021-2030 (USD Million)
• Table 13 Global Exome Sequencing Services Market, by Country/Region, 2021-2030 (USD Million)
• Table 14 Global ChIP Sequencing Services Market, by Country/Region, 2021-2030 (USD Million)
• Table 15 Global Methyl Sequencing Services Market, by Country/Region, 2021-2030 (USD Million)
• Table 16 Global Other NGS Services Market, by Country/Region, 2021-2030 (USD Million)
• Table 17 Global NGS Services Market, by Technology, 2021-2030 (USD Million)
• Table 18 Global NGS Services Market for Sequencing by Synthesis, by Country/Region, 2021-2030 (USD Million)
• Table 19 Global NGS Services Market for Ion Semiconductor Sequencing, by Country/Region, 2021-2030 (USD Million)
• Table 20 Global NGS Services Market for Single-molecule Real-time Sequencing, by Country/Region, 2021-2030 (USD Million)
• Table 21 Global NGS Services Market for Nanopore Sequencing, by Country/Region, 2021-2030 (USD Million)
• Table 22 Global DNA Nanoball Sequencing, by Country/Region, 2021-2030 (USD Million)
• Table 23 Global NGS Services Market, by Application, 2021-2030 (USD Million)
• Table 24 Global NGS Services Market for Research Applications, by Type 2021-2030 (USD Million)
• Table 25 Global NGS Services Market for Research Applications, by Country/Region, 2021-2030 (USD Million)
• Table 26 Global NGS Services Market for Drug Discovery, by Country/Region, 2021-2030 (USD Million)
• Table 27 Global NGS Services Market for Agriculture & Animal Research, by Country/Region, 2021-2030 (USD Million)
• Table 28 Global NGS Services Market for Other Research Applications, by Country/Region, 2021-2030 (USD Million)
• Table 29 Global NGS Services Market for Clinical Applications, by Type 2021-2030 (USD Million)
• Table 30 Global NGS Services Market for Clinical Applications, by Country/Region, 2021-2030 (USD Million)
• Table 31 Currently Available Targeted Therapies and Corresponding Biomarkers
• Table 32 Global NGS Services Market for Oncology, by Country/Region, 2021-2030 (USD Million)
• Table 33 Global NGS Services Market for Reproductive Health, by Country/Region, 2021-2030 (USD Million)
• Table 34 HIV Prevalence Among Adults, by Region (2017 Vs. 2021)
• Table 35 Global NGS Services Market for Infectious Diseases, by Country/Region, 2021-2030 (USD Million)
• Table 36 Global NGS Services Market for Other Clinical Applications, by Country/Region, 2021-2030 (USD Million)
• Table 37 Global NGS Services Market, by End User, 2021-2030 (USD Million)
• Table 38 Global NGS Services Market for Hospitals and Diagnostic Laboratories, by Country/Region, 2021-2030 (USD Million)
• Table 39 Global NGS Services Market for Pharmaceutical & Biotechnology Companies, by Country/Region, 2021-2030 (USD Million)
• Table 40 Global NGS Services Market for Academic Institutes & Research Centers, by Country/Region, 2021-2030 (USD Million)
• Table 41 Global NGS Services Market for Other End Users, by Country/Region, 2021-2030 (USD Million)
• Table 42 Global NGS Services Market, by Country/Region, 2021-2030 (USD Million)
• Table 43 North America: NGS Services Market, by Country, 2021-2030 (USD Million)
• Table 44 North America: NGS Services Market, by Type, 2021-2030 (USD Million)
• Table 45 North America: NGS Services Market, by Technology, 2021-2030 (USD Million)
• Table 46 North America: NGS Services Market, by Application, 2021-2030 (USD Million)
• Table 47 North America: NGS Services Market for Clinical Applications, by Type, 2021-2030 (USD Million)
• Table 48 North America: NGS Services Market for Research Applications, by Type, 2021-2030 (USD Million)
• Table 49 North America: NGS Services Market, by End User, 2021-2030 (USD Million)
• Table 50 U.S.: Key Macro & Micro Indicators
• Table 51 U.S.: NGS Services Market, by Type, 2021-2030 (USD Million)
• Table 52 U.S.: NGS Services Market, by Technology, 2021-2030 (USD Million)
• Table 53 U.S.: NGS Services Market, by Application, 2021-2030 (USD Million)
• Table 54 U.S.: NGS Services Market for Clinical Applications, by Type, 2021-2030 (USD Million)
• Table 55 U.S.: NGS Services Market for Research Applications, by Type, 2021-2030 (USD Million)
• Table 56 U.S.: NGS Services Market, by End User, 2021-2030 (USD Million)
• Table 57 Canada: Key Macro & Micro Indicators
• Table 58 Canada: NGS Services Market, by Type, 2021-2030 (USD Million)
• Table 59 Canada: NGS Services Market, by Technology, 2021-2030 (USD Million)
• Table 60 Canada: NGS Services Market, by Application, 2021-2030 (USD Million)
• Table 61 Canada: NGS Services Market for Clinical Applications, by Type, 2021-2030 (USD Million)
• Table 62 Canada: NGS Services Market for Research Applications, by Type, 2021-2030 (USD Million)
• Table 63 Canada: NGS Services Market, by End User, 2021-2030 (USD Million)
• Table 64 Europe: NGS Services Market, by Country/Region, 2021-2030 (USD Million)
• Table 65 Europe: NGS Services Market, by Type, 2021-2030 (USD Million)
• Table 66 Europe: NGS Services Market, by Technology, 2021-2030 (USD Million)
• Table 67 Europe: NGS Services Market, by Application, 2021-2030 (USD Million)
• Table 68 Europe: NGS Services Market for Clinical Applications, by Type, 2021-2030 (USD Million)
• Table 69 Europe: NGS Services Market for Research Applications, by Type, 2021-2030 (USD Million)
• Table 70 Europe: NGS Services Market, by End User, 2021-2030 (USD Million)
• Table 71 Germany: Key Macro & Micro Indicators
• Table 72 Germany: NGS Services Market, by Type, 2021-2030 (USD Million)
• Table 73 Germany: NGS Services Market, by Technology, 2021-2030 (USD Million)
• Table 74 Germany: NGS Services Market, by Application, 2021-2030 (USD Million)
• Table 75 Germany: NGS Services Market for Clinical Applications, by Type, 2021-2030 (USD Million)
• Table 76 Germany: NGS Services Market for Research Applications, by Type, 2021-2030 (USD Million)
• Table 77 Germany: NGS Services Market, by End User, 2021-2030 (USD Million)
• Table 78 France: Key Macro & Indicators
• Table 79 France: NGS Services Market, by Type, 2021-2030 (USD Million)
• Table 80 France: NGS Services Market, by Technology, 2021-2030 (USD Million)
• Table 81 France: NGS Services Market, by Application, 2021-2030 (USD Million)
• Table 82 France: NGS Services Market for Clinical Applications, by Type, 2021-2030 (USD Million)
• Table 83 France: NGS Services Market for Research Applications, by Type, 2021-2030 (USD Million)
• Table 84 France: NGS Services Market, by End User, 2021-2030 (USD Million)
• Table 85 U.K.: Key Macro & Micro Indicators
• Table 86 U.K.: NGS Services Market, by Type, 2021-2030 (USD Million)
• Table 87 U.K.: NGS Services Market, by Technology, 2021-2030 (USD Million)
• Table 88 U.K.: NGS Services Market, by Application, 2021-2030 (USD Million)
• Table 89 U.K.: NGS Services Market for Clinical Applications, by Type, 2021-2030 (USD Million)
• Table 90 U.K.: NGS Services Market for Research Applications, by Type, 2021-2030 (USD Million)
• Table 91 U.K.: NGS Services Market, by End User, 2021-2030 (USD Million)
• Table 92 Italy: Key Macro & Micro Indicators
• Table 93 Italy.: NGS Services Market, by Type, 2021-2030 (USD Million)
• Table 94 Italy: NGS Services Market, by Technology, 2021-2030 (USD Million)
• Table 95 Italy: NGS Services Market, by Application, 2021-2030 (USD Million)
• Table 96 Italy: NGS Services Market for Clinical Applications, by Type, 2021-2030 (USD Million)
• Table 97 Italy: NGS Services Market for Research Applications, by Type, 2021-2030 (USD Million)
• Table 98 Italy: NGS Services Market, by End User, 2021-2030 (USD Million)
• Table 99 Spain: Key Macro & Micro Indicators
• Table 100 Spain: NGS Services Market, by Type, 2021-2030 (USD Million)
• Table 101 Spain: NGS Services Market, by Technology, 2021-2030 (USD Million)
• Table 102 Spain: NGS Services Market, by Application, 2021-2030 (USD Million)
• Table 103 Spain: NGS Services Market for Clinical Applications, by Type, 2021-2030 (USD Million)
• Table 104 Spain: NGS Services Market for Research Applications, by Type, 2021-2030 (USD Million)
• Table 105 Spain: NGS Services Market, by End User, 2021-2030 (USD Million)
• Table 106 Estimated Number of New Cancer Cases - 2020 Vs 2030
• Table 107 RoE: NGS Services Market, by Type, 2021-2030 (USD Million)
• Table 108 RoE: NGS Services Market, by Technology, 2021-2030 (USD Million)
• Table 109 RoE: NGS Services Market, by Application, 2021-2030 (USD Million)
• Table 110 RoE: NGS Services Market for Clinical Applications, by Type, 2021-2030 (USD Million)
• Table 111 RoE: NGS Services Market for Research Applications, by Type, 2021-2030 (USD Million)
• Table 112 RoE: NGS Services Market, by End User, 2021-2030 (USD Million)
• Table 113 Asia-Pacific: NGS Services Market, by Country/Region, 2021-2030 (USD Million)
• Table 114 Asia-Pacific: NGS Services Market, by Type, 2021-2030 (USD Million)
• Table 115 Asia-Pacific: NGS Services Market, by Technology, 2021-2030 (USD Million)
• Table 116 Asia-Pacific: NGS Services Market, by Application, 2021-2030 (USD Million)
• Table 117 Asia-Pacific: NGS Services Market for Clinical Applications, by Type, 2021-2030 (USD Million)
• Table 118 Asia-Pacific: NGS Services Market for Research Applications, by Type, 2021-2030 (USD Million)
• Table 119 Asia-Pacific: NGS Services Market, by End User, 2021-2030 (USD Million)
• Table 120 China: Key Macro & Micro Indicators
• Table 121 China: NGS Services Market, by Type, 2021-2030 (USD Million)
• Table 122 China: NGS Services Market, by Technology, 2021-2030 (USD Million)
• Table 123 China: NGS Services Market, by Application, 2021-2030 (USD Million)
• Table 124 China: NGS Services Market for Clinical Applications, by Type, 2021-2030 (USD Million)
• Table 125 China: NGS Services Market for Research Applications, by Type, 2021-2030 (USD Million)
• Table 126 China: NGS Services Market, by End User, 2021-2030 (USD Million)
• Table 127 Japan: Key Macro & Micro Indicators
• Table 128 Japan: NGS Services Market, by Type, 2021-2030 (USD Million)
• Table 129 Japan: NGS Services Market, by Technology, 2021-2030 (USD Million)
• Table 130 Japan: NGS Services Market, by Application, 2021-2030 (USD Million)
• Table 131 Japan: NGS Services Market for Clinical Applications, by Type, 2021-2030 (USD Million)
• Table 132 Japan: NGS Services Market for Research Applications, by Type, 2021-2030 (USD Million)
• Table 133 Japan: NGS Services Market, by End User, 2021-2030 (USD Million)
• Table 134 India: Key Macro & Micro Indicators
• Table 135 India: NGS Services Market, by Type, 2021-2030 (USD Million)
• Table 136 India: NGS Services Market, by Technology, 2021-2030 (USD Million)
• Table 137 India: NGS Services Market, by Application, 2021-2030 (USD Million)
• Table 138 India: NGS Services Market for Clinical Applications, by Type, 2021-2030 (USD Million)
• Table 139 India: NGS Services Market for Research Applications, by Type, 2021-2030 (USD Million)
• Table 140 India: NGS Services Market, by End User, 2021-2030 (USD Million)
• Table 141 Estimated Number of New Cancer Cases - 2020 Vs 2030
• Table 142 RoAPAC: NGS Services Market, by Type, 2021-2030 (USD Million)
• Table 143 RoAPAC: NGS Services Market, by Technology, 2021-2030 (USD Million)
• Table 144 RoAPAC: NGS Services Market, by Application, 2021-2030 (USD Million)
• Table 145 RoAPAC: NGS Services Market for Clinical Applications, by Type, 2021-2030 (USD Million)
• Table 146 RoAPAC: NGS Services Market for Research Applications, by Type, 2021-2030 (USD Million)
• Table 147 RoAPAC: NGS Services Market, by End User, 2021-2030 (USD Million)
• Table 148 Latin America: NGS Services Market, by Type, 2021-2030 (USD Million)
• Table 149 Latin America: NGS Services Market, by Technology, 2021-2030 (USD Million)
• Table 150 Latin America: NGS Services Market, by Application, 2021-2030 (USD Million)
• Table 151 Latin America: NGS Services Market for Clinical Applications, by Type, 2021-2030 (USD Million)
• Table 152 Latin America: NGS Services Market for Research Applications, by Type, 2021-2030 (USD Million)
• Table 153 Latin America: NGS Services Market, by End User, 2021-2030 (USD Million)
• Table 154 Middle East & Africa: NGS Services Market, by Type, 2021-2030 (USD Million)
• Table 155 Middle East & Africa: NGS Services Market, by Technology, 2021-2030 (USD Million)
• Table 156 Middle East & Africa: NGS Services Market, by Application, 2021-2030 (USD Million)
• Table 157 Middle East & Africa: NGS Services Market for Clinical Applications, by Type, 2021-2030 (USD Million)
• Table 158 Middle East & Africa: NGS Services Market for Research Applications, by Type, 2021-2030 (USD Million)
• Table 159 Middle East & Africa: NGS Services Market, by End User, 2021-2030 (USD Million)
• Table 160 Recent Developments, by Company, 2020-2023
• Table 161 Key Services Offered by Companies Operating NGS Services Market: Competitive Benchmarking

The Next Generation Sequencing (NGS) Services Market By Type (Targeted, RNA, De Novo, WES, WGS) Technology (Sequencing by Synthesis, Ion Semiconductor, SMRT, Nanopore) Application (Research, Clinical [Oncology, Reproductive]) End User-Global Forecast to 2030

The next generation sequencing services market is expected to grow at a CAGR of 19.9% from 2023 to 2030 to reach $20.39 billion by 2030. Following thorough secondary and primary research and in-depth analysis of the market scenario, the report discusses key industry drivers, restraints, challenges, and opportunities.

The growth of this market is mainly attributed to the reduced cost of NGS procedures, the development and approval of new targeted therapies, the rising prevalence of cancer, partnerships between NGS service providers and pharmaceutical companies, the high cost of sequencing infrastructure, and technological advancements in NGS. In addition, advancements in sequencing data analytics and the increasing applications of NGS in cancer and agri-genomics research are expected to offer significant growth opportunities for NGS service providers.

However, the availability of alternative technologies, lack of skilled professionals for sample preparation and analysis, and actionable mutations for precision medicine may restrain the growth of the NGS services market. Moreover, regulatory & standardization concerns in diagnostic testing and the ethical issues & costs related to non-invasive prenatal genetic testing are major challenges to the growth of this market.

Based on type, the global NGS services market is segmented into targeted sequencing services, whole-genome sequencing services, RNA sequencing services, exome sequencing services, de novo sequencing services, ChIP sequencing services, methyl sequencing services, and other NGS services. In 2023, the targeted sequencing services segment is estimated to account for the largest share of the global NGS services market. The large share of this segment can be attributed to the relatively lower cost, faster turnaround time, and accurate, easy-to-interpret results of targeted sequencing in the study of disease-related genes.

Based on technology, the global NGS services market is segmented into sequencing by synthesis, ion semiconductor sequencing, single-molecule real-time sequencing, nanopore sequencing, and DNA nanoball sequencing. In 2023, the sequencing by synthesis segment is estimated to account for the largest share of the global NGS services market. The large share of this segment is attributed to its highest yield of error-free throughput, base call value above Q30, and higher accuracy in DNA sequencing compared to other sequencing technologies available in the market.

Based on application, the global NGS services market is segmented into research applications and clinical applications. In 2023, the research applications segment is estimated to account for the largest share of the global NGS services market. This segment's large share is mainly attributed to the increasing demand for gene-based medicines, growing investments in drug research and development activities, and increasing research programs for personalized medicine.

Based on end user, the global NGS services market is segmented into hospitals & clinics, pharmaceutical & biotechnology companies, academic institutes & research centers, and other end users. In 2023, the hospitals & clinics segment is estimated to account for the largest share of the global NGS services market. The largest share of this segment is attributed to factors such as high capital requirements for building in-house NGS capabilities in hospitals & clinics, the rising prevalence of cancer and other chronic diseases, the growing demand for advanced medical treatments, and the rising number of biomarker-based therapies.

An in-depth analysis of the geographical scenario of the next generation sequencing services market provides detailed qualitative and quantitative insights about the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. North America is expected to command the largest share of the global next generation sequencing services market in 2023, followed by Europe and Asia-Pacific.

Key companies operating in the global next generation sequencing services market are Illumina, Inc. (U.S.), QIAGEN N.V. (Netherlands), PerkinElmer, Inc. (U.S.), Eurofins Scientific S.E. (Luxembourg), Macrogen, Inc. (South Korea), LGC Limited (U.K.), GENEWIZ, Inc. (U.S.), Beijing Genomics Institute (China), MedGenome, Inc. (U.S.), DNA Link, Inc. (South Korea), Novogene Co., Ltd. (China), CD Genomics (U.S.), SeqLL, Inc. (U.S.), Otogenetics Corporation (U.S.), Foundation Medicine, Inc. (U.S.), Quest Diagnostics Incorporated (U.S.), and Invitae Corporation (U.S.).

Scope of the Report

Next Generation Sequencing Services Market Assessment-by Type

• Targeted Sequencing Services
• RNA Sequencing Services
• De Novo Sequencing Services
• Exome Sequencing Services
• Chip Sequencing Services
• Whole Genome Sequencing Services
• Methyl Sequencing Services
• Other Services

Next Generation Sequencing Services Market Assessment-Technology

• Sequencing By Synthesis
• Ion Semiconductor Sequencing
• Single-molecule Real-time Sequencing
• Nanopore Sequencing
• DNA Nanoball Sequencing

Next generation Sequencing Services Market Assessment-Application

• Research Applications
  • Drug Discovery
  • Agriculture & Animal Research
  • Other Research Applications
• Clinical Applications
  • Reproductive Health Diagnosis
  • Oncology
  • Infectious Diseases
  • Other Clinical Applications

(Other research applications include food microbiology, microbiota analysis in the beverage industry, and environmental studies, and other clinical applications include the detection of genetic aberrations in neurological disorders, rare diseases, metabolic and immune disorders, and food-borne illnesses)

Next Generation Sequencing Services Market Assessment-by End User

• Hospitals & Diagnostic Laboratories
• Pharmaceutical & Biotechnology Companies
• Academic Institutes & Research Centers
• Other End Users

Next Generation Sequencing Services Market Assessment-by Geography

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe (RoE)
• Asia-Pacific (APAC)
  • China
  • Japan
  • China
  • India
  • Rest of Asia Pacific (RoAPAC)
• Latin America
• Middle East & Africa

TABLE OF CONTENTS

1. Introduction

• 1.1. Market Definition & Scope
• 1.2. Market Ecosystem
• 1.3. Currency & Limitations
• 1.4. Key Stakeholders

2. Research Methodology

• 2.1. Research Approach
• 2.2. Process of Data Collection and Validation
  • 2.2.1. Secondary Research
  • 2.2.2. Primary Research/Interviews with Key Opinion Leaders from the Industry
• 2.3. Market Sizing and Forecasting
  • 2.3.1. Market Size Estimation Approach
  • 2.3.2. Growth Forecast Approach
  • 2.3.3. Market Share Analysis
• 2.4. Assumptions for the Study

3. Executive Summary

4. Market Insights

• 4.1. Overview
• 4.2. Factors Affecting Market Growth
  • 4.2.1. Impact Analysis
  • 4.2.2. Factor Analysis
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Buyers
  • 4.3.2. Bargaining Power of Suppliers
  • 4.3.3. Threat of Substitutes
  • 4.3.4. Threat of New Entrants
  • 4.3.5. Degree of Competition
• 4.4. Pricing Analysis
• 4.5. Regulatory Analysis
  • 4.5.1. Overview
  • 4.5.2. North America
    • 4.5.2.1. U.S.
    • 4.5.2.2. Canada
  • 4.5.3. Europe
  • 4.5.4. Asia-Pacific
    • 4.5.4.1. China
    • 4.5.4.2. Japan
    • 4.5.4.3. India
  • 4.5.5. Latin America
  • 4.5.6. Middle East
• 4.6. Industry & Technology Trends
  • 4.6.1. Installation of In-house NGS Systems to Hinder Market Growth
  • 4.6.2. Growing Utilization of NGS Services in Disease Diagnostics and Precision Medicine

5. NGS Services Market Assessment-by Type

• 5.1. Overview
• 5.2. Targeted Sequencing Services
• 5.3. RNA Sequencing Services
• 5.4. Whole Genome Sequencing Services
• 5.5. De Novo Sequencing Services
• 5.6. Exome Sequencing Services
• 5.7. ChIP Sequencing Services
• 5.8. Methyl Sequencing Services
• 5.9. Other NGS Services

6. NGS Services Market Assessment-by Technology

• 6.1. Overview
• 6.2. Sequencing by Synthesis
• 6.3. Ion Semiconductor Sequencing
• 6.4. Single-molecule Real-time Sequencing (SMRT)
• 6.5. Nanopore Sequencing
• 6.6. DNA Nanoball Sequencing

7. NGS Services Market Assessment-by Application

• 7.1. Overview
• 7.2. Research Applications
  • 7.2.1. Drug Discovery
  • 7.2.2. Agriculture & Animal Research
  • 7.2.3. Other Research Applications
• 7.3. Clinical Applications
  • 7.3.1. Oncology
  • 7.3.2. Reproductive Health
  • 7.3.3. Infectious Diseases
  • 7.3.4. Other Clinical Applications

8. NGS Services Market Assessment-by End User

• 8.1. Overview
• 8.2. Hospitals and Diagnostic Laboratories
• 8.3. Pharmaceutical & Biotechnology Companies
• 8.4. Academic Institutes & Research Centers
• 8.5. Other End Users

9. NGS Services Market Assessment - by Geography

• 9.1. Overview
• 9.2. North America
  • 9.2.1. U.S.
  • 9.2.2. Canada
• 9.3. Europe
  • 9.3.1. Germany
  • 9.3.2. France
  • 9.3.3. U.K.
  • 9.3.4. Italy
  • 9.3.5. Spain
  • 9.3.6. Rest of Europe (RoE)
• 9.4. Asia-Pacific
  • 9.4.1. China
  • 9.4.2. Japan
  • 9.4.3. India
  • 9.4.4. Rest of Asia-Pacific (RoAPAC)
• 9.5. Latin America
• 9.6. Middle East & Africa

10. Competition Analysis

• 10.1. Overview
• 10.2. Key Growth Strategies
• 10.3. Competitive Benchmarking
• 10.4. Market Share Analysis (2022)
  • 10.4.1. Eurofins Scientific S.E.
  • 10.4.2. Illumina, Inc.
  • 10.4.3. Foundation Medicine, Inc. (Subsidiary of F. Hoffmann-La Roche AG) (U.S.)
  • 10.4.4. Invitae Corporation (U.S.)
  • 10.4.5. Beijing Genomics Institute (BGI) (China)
  • 10.4.6. Novogene Co., Ltd. (China)
  • 10.4.7. Perkinelmer, Inc. (U.S.)
• 10.5. Competitive Dashboard
  • 10.5.1. Industry Leaders
  • 10.5.2. Market Differentiators
  • 10.5.3. Vanguards
  • 10.5.4. Emerging Companies

11. Company Profiles

• 11.1. Illumina, Inc.
• 11.2. Eurofins Scientific S.E.
• 11.3. Invitae Corporation
• 11.4. Foundation Medicine, Inc. (Subsidiary of F. Hoffmann-La Roche AG)
• 11.5. Beijing Genomics Institute (BGI)
• 11.6. Novogene Co., Ltd.
• 11.7. Perkinelmer, Inc.
• 11.8. Macrogen, Inc.
• 11.9. QIAGEN N.V.
• 11.10. LGC Limited
• 11.11. GENEWIZ, Inc. (Subsidiary of Azenta, Inc.)
• 11.12. MedGenome, Inc.
• 11.13. DNA Link, Inc.
• 11.14. CD Genomics
• 11.15. Otogenetics Corporation
• 11.16. Quest Diagnostics Incorporated

12. Appendix

• 12.1. Available Customization
• 12.2. Related Reports